-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Ensysce Biosciences, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2017 to 31 Mar 2025.
- Ensysce Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $1,257,826, a 78% decline year-over-year.
- Ensysce Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9,881,173, a 13% increase from 2023.
- Ensysce Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $8,755,884, a 0.11% decline from 2022.
- Ensysce Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $8,765,905, a 57% decline from 2021.